Gozetotide alf-18
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
165 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Prostatic neoplasms | D011471 | — | C61 | 27 | 35 | 18 | 6 | 50 | 127 |
| Adenocarcinoma | D000230 | — | — | 3 | 7 | 1 | 1 | 2 | 14 |
| Castration-resistant prostatic neoplasms | D064129 | — | — | 3 | 3 | — | 3 | 1 | 9 |
| Neoplasms | D009369 | — | C80 | 2 | 4 | — | 1 | 2 | 9 |
| Urogenital neoplasms | D014565 | EFO_0003863 | D07 | 1 | 2 | — | 1 | 1 | 4 |
| Prostatic diseases | D011469 | — | N42.9 | 1 | 2 | — | 1 | — | 3 |
| Neoplasms by site | D009371 | — | — | — | 1 | — | 1 | — | 2 |
| Male genital diseases | D005832 | EFO_0009555 | N50.9 | — | 1 | — | 1 | — | 2 |
| Male genital neoplasms | D005834 | — | — | — | 1 | — | 1 | — | 2 |
| Male urogenital diseases | D052801 | — | — | — | — | — | 1 | — | 1 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Disease | D004194 | EFO_0000408 | R69 | — | 3 | 4 | — | 4 | 10 |
| Renal cell carcinoma | D002292 | EFO_0000376 | — | 4 | 3 | 1 | — | 3 | 9 |
| Kidney neoplasms | D007680 | EFO_0003865 | C64 | 2 | 3 | 1 | — | 1 | 5 |
| Recurrence | D012008 | — | — | — | — | 1 | — | 1 | 2 |
| Prostatectomy | D011468 | — | — | — | — | 1 | — | — | 1 |
| Radiotherapy | D011878 | — | — | — | — | 1 | — | — | 1 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 2 | 1 | — | — | 2 | 5 |
| Thyroid neoplasms | D013964 | EFO_0003841 | — | — | 1 | — | — | 2 | 3 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 1 | 1 | — | — | — | 2 |
| Triple negative breast neoplasms | D064726 | — | — | — | 2 | — | — | — | 2 |
| Hepatocellular carcinoma | D006528 | — | C22.0 | — | 2 | — | — | — | 2 |
| Liver neoplasms | D008113 | EFO_1001513 | C22.0 | — | 2 | — | — | — | 2 |
| Uterine neoplasms | D014594 | EFO_0003859 | C55 | — | 1 | — | — | — | 1 |
| Female genital neoplasms | D005833 | — | — | — | 1 | — | — | — | 1 |
| Oncogenes | D009857 | — | — | — | 1 | — | — | — | 1 |
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Positron emission tomography computed tomography | D000072078 | — | — | 3 | — | — | — | 1 | 4 |
| Brain neoplasms | D001932 | EFO_0003833 | C71 | 1 | — | — | — | 2 | 3 |
| Glioma | D005910 | EFO_0000520 | — | 2 | — | — | — | 1 | 3 |
| Head and neck neoplasms | D006258 | — | — | 1 | — | — | — | 1 | 2 |
| Prostatic hyperplasia | D011470 | EFO_0000284 | N40 | 1 | — | — | — | 1 | 2 |
| Neuroendocrine carcinoma | D018278 | — | — | 1 | — | — | — | 1 | 2 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | 1 | — | — | — | 1 | 2 |
| Lobular carcinoma | D018275 | EFO_0000570 | — | 1 | — | — | — | — | 1 |
| Invasive hydatidiform mole | D002820 | — | D39.2 | 1 | — | — | — | — | 1 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 1 | — | — | — | — | 1 |
Show 5 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neuroendocrine tumors | D018358 | EFO_1001901 | D3A.8 | — | — | — | — | 4 | 4 |
| Glioblastoma | D005909 | EFO_0000515 | — | — | — | — | — | 3 | 3 |
| Positron-emission tomography | D049268 | — | — | — | — | — | — | 3 | 3 |
| Gastrointestinal neoplasms | D005770 | — | C26.9 | — | — | — | — | 2 | 2 |
| Papillary thyroid cancer | D000077273 | — | — | — | — | — | — | 1 | 1 |
| Medullary carcinoma | D018276 | — | — | — | — | — | — | 1 | 1 |
| Multiple myeloma | D009101 | — | C90.0 | — | — | — | — | 1 | 1 |
| Urologic neoplasms | D014571 | — | C64-C68 | — | — | — | — | 1 | 1 |
| Sarcoma | D012509 | — | — | — | — | — | — | 1 | 1 |
| Transitional cell carcinoma | D002295 | — | — | — | — | — | — | 1 | 1 |
Show 8 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 89 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
45 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use